Form D · Biotechnology
BIOCURITY PHARMACEUTICALS INC.
West Palm Beach, FL · CIK 0001639681
Offering snapshot reported Jun 21, 2023 · SEC filing
- Reported sold
- $16.9K Offering amount: $650K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $2.25K Reported outside-investor minimum
- First sale
- May 3, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 21, 2023 | Initial | $16,900 | No comparison | 5 | SEC filing |
| Nov 30, 2022 | Initial | $11,250 | No comparison | 2 | SEC filing |
| Apr 13, 2022 | Initial | $75,150 | No comparison | 1 | SEC filing |
| Sep 1, 2021 | Initial | $18,900 | No comparison | Not reported | SEC filing |
| May 27, 2021 | Initial | $25,200 | No comparison | 2 | SEC filing |
| Oct 2, 2019 | Initial | $15,000 | No comparison | 1 | SEC filing |
| May 6, 2019 | Initial | $0 | No comparison | 1 | SEC filing |
| Feb 7, 2019 | Initial | $50,000 | No comparison | 2 | SEC filing |
| Dec 14, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 21, 2018 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Nov 16, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jun 19, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 1, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 14, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Aug 8, 2016 | Amendment | $204,000 | No comparison | 1 | SEC filing |
| Jun 30, 2016 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Apr 15, 2016 | Initial | $105,000 | No comparison | 4 | SEC filing |
| May 29, 2015 | Amendment | $0 | No comparison | 3 | SEC filing |
| Apr 23, 2015 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Apr 16, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-484733
Source: Form D, filed Jun 21, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cheryl Baker | Director, Executive |
| Nancy Cass | Director |
| Sam Merchant | Director |
| Aslam Merchant | Director |
| Aslams Merchant | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7750 Okeechobee Blvd Ste 4 Mb 3058
West Palm Beach, FL, 33411
West Palm Beach, FL, 33411